GABELLI FUNDS LLC - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 45 filers reported holding JUNIPER PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$253,000
-30.5%
53,182
-18.2%
0.00%
-50.0%
Q4 2016$364,000
+0.8%
65,0000.0%0.00%0.0%
Q3 2016$361,000
-6.5%
65,000
+18.2%
0.00%0.0%
Q2 2016$386,000
+6.0%
55,0000.0%0.00%0.0%
Q1 2016$364,000
-35.8%
55,0000.0%0.00%
-33.3%
Q4 2015$567,000
+7.0%
55,000
+22.3%
0.00%0.0%
Q3 2015$530,000
-53.3%
44,954
-63.8%
0.00%
-50.0%
Q2 2015$1,135,000124,0960.01%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 328,133$1,838,0001.22%
Stonepine Capital Management, LLC 228,392$1,279,0000.76%
Krensavage Asset Management, LLC 290,853$1,629,0000.58%
ALGERT GLOBAL LLC 84,045$471,0000.14%
HEARTLAND ADVISORS INC 400,000$2,240,0000.12%
TFS CAPITAL LLC 16,912$95,0000.02%
Spark Investment Management LLC 50,500$282,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$1,009,0000.01%
GSA CAPITAL PARTNERS LLP 20,792$116,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 24,390$137,0000.00%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders